Insider · CIK 0001376260

LOWE CHRISTOPHER P.

Reports to the SEC for 5 companies · HAYWARD, CA

sec.gov

Transactions

Companies

Filings

CIK

0001376260

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-08-25	VINCVincerx Pharma, Inc.P Purchase	Director	PPurchase	+11.6K sh	$1.65	+$19.1K	40,000
2022-08-24	VINCVincerx Pharma, Inc.P Purchase	Director	PPurchase	+18.4K sh	$1.65	+$30.3K	28,400
2022-05-26	VINCVincerx Pharma, Inc. · Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2022-03-03	IRLAIRulya Therapeutics Inc.A Award	Interim CEO, COO & CFO	AAward	+175K sh	—	—	265,000
2022-01-03	IRLAIRulya Therapeutics Inc. · Stock Option (right to buy)A Award	Interim CEO, COO & CFO	AAward	+125K sh	—	—	125,000
2021-11-16	IRLAIRulya Therapeutics Inc.M Exercise/Conversion	Interim CEO, COO & CFO	MExercise/Conversion	+30K sh	$2.23	+$66.9K	90,000
2021-11-16	IRLAIRulya Therapeutics Inc. · Stock Option (right to buy)M Exercise/Conversion	Interim CEO, COO & CFO	MExercise/Conversion	−30K sh	—	—	103,294
2021-10-05	IRLAIRulya Therapeutics Inc.M Exercise/Conversion	Interim CEO, COO & CFO	MExercise/Conversion	+4,963 sh	$54.85	+$272K	64,963
2021-10-05	IRLAIRulya Therapeutics Inc.S Sale	Interim CEO, COO & CFO	SSale	−4,963 sh	$98.50	−$489K	60,000
2021-10-05	IRLAIRulya Therapeutics Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Interim CEO, COO & CFO	MExercise/Conversion	−4,963 sh	—	—	95,037
2021-08-17	IRLAIRulya Therapeutics Inc.M Exercise/Conversion	Interim CEO, COO & CFO	MExercise/Conversion	+30K sh	$2.23	+$66.9K	60,000
2021-08-17	IRLAIRulya Therapeutics Inc. · Stock Option (right to buy)M Exercise/Conversion	Interim CEO, COO & CFO	MExercise/Conversion	−30K sh	—	—	133,294
2021-08-16	IRLAIRulya Therapeutics Inc.M Exercise/Conversion	Interim CEO, COO & CFO	MExercise/Conversion	+22K sh	$2.23	+$49.1K	52,000
2021-08-16	IRLAIRulya Therapeutics Inc.S Sale	Interim CEO, COO & CFO	SSale	−9,158 sh	$94.23	−$863K	42,842
2021-08-16	IRLAIRulya Therapeutics Inc.S Sale	Interim CEO, COO & CFO	SSale	−7,335 sh	$95.02	−$697K	35,507
2021-08-16	IRLAIRulya Therapeutics Inc.S Sale	Interim CEO, COO & CFO	SSale	−2,330 sh	$96.32	−$224K	33,177
2021-08-16	IRLAIRulya Therapeutics Inc.S Sale	Interim CEO, COO & CFO	SSale	−1,100 sh	$97.28	−$107K	32,077
2021-08-16	IRLAIRulya Therapeutics Inc.S Sale	Interim CEO, COO & CFO	SSale	−2,077 sh	$98.90	−$205K	30,000
2021-08-16	IRLAIRulya Therapeutics Inc. · Stock Option (right to buy)M Exercise/Conversion	Interim CEO, COO & CFO	MExercise/Conversion	−22K sh	—	—	163,294
2021-06-30	VINCVincerx Pharma, Inc.P Purchase	Director	PPurchase	+3,600 sh	$12.66	+$45.6K	10,000
2021-06-30	IRLAIRulya Therapeutics Inc.M Exercise/Conversion	Interim CEO, COO & CFO	MExercise/Conversion	+30K sh	$2.23	+$66.9K	30,000
2021-06-30	IRLAIRulya Therapeutics Inc. · Stock Option (right to buy)M Exercise/Conversion	Interim CEO, COO & CFO	MExercise/Conversion	−30K sh	—	—	185,294
2021-06-29	VINCVincerx Pharma, Inc.P Purchase	Director	PPurchase	+6,400 sh	$12.59	+$80.6K	6,400
2021-06-28	IRLAIRulya Therapeutics Inc.M Exercise/Conversion	Interim CEO, COO & CFO	MExercise/Conversion	+20K sh	$2.23	+$44.6K	20,000
2021-06-28	IRLAIRulya Therapeutics Inc.S Sale	Interim CEO, COO & CFO	SSale	−7,724 sh	$53.39	−$412K	12,276
2021-06-28	IRLAIRulya Therapeutics Inc.S Sale	Interim CEO, COO & CFO	SSale	−7,079 sh	$54.13	−$383K	5,197
2021-06-28	IRLAIRulya Therapeutics Inc.S Sale	Interim CEO, COO & CFO	SSale	−4,153 sh	$55.11	−$229K	1,044
2021-06-28	IRLAIRulya Therapeutics Inc.S Sale	Interim CEO, COO & CFO	SSale	−1,044 sh	$56.16	−$58.6K	0
2021-06-28	IRLAIRulya Therapeutics Inc. · Stock Option (right to buy)M Exercise/Conversion	Interim CEO, COO & CFO	MExercise/Conversion	−20K sh	—	—	215,594
2021-05-13	VINCVincerx Pharma, Inc. · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2021-02-09	IRLAIRulya Therapeutics Inc. · Employee Stock Option (right to buy)A Award	Interim CEO, COO & CFO	AAward	+40K sh	—	—	40,000
2020-12-23	VINCVincerx Pharma, Inc. · Stock Option (right to buy)A Award	Director	AAward	+6,667 sh	—	—	6,667
2020-12-11	IRLAIRulya Therapeutics Inc. · Stock Option (Right to Buy)A Award	Interim CEO, COO & CFO	AAward	+100K sh	—	—	100,000
2020-12-11	IRLAIRulya Therapeutics Inc. · Stock Option (Right to Buy)A Award	Interim CEO, COO & CFO	AAward	+100K sh	—	—	100,000
2020-05-14	IRLAIRulya Therapeutics Inc. · Stock Option (Right to Buy)A Award	Interim CEO, COO & CFO	AAward	+30K sh	—	—	30,000
2020-02-06	IRLAIRulya Therapeutics Inc. · Stock Option (Right to Buy)A Award	Interim CEO, COO & CFO	AAward	+100K sh	—	—	100,000
2016-07-27	HANSEN MEDICAL INCM Exercise/Conversion	Director, Interim CFO	MExercise/Conversion	+100K sh	—	—	104,250
2016-07-27	HANSEN MEDICAL INCD Disposition to Issuer	Director, Interim CFO	DDisposition to Issuer	−104K sh	$4.00	−$417K	0
2016-07-27	HANSEN MEDICAL INCRestricted Stock UnitD Disposition to Issuer	Director, Interim CFO	DDisposition to Issuer	−100K sh	—	—	0
2016-02-02	HANSEN MEDICAL INCRestricted Stock UnitA Award	Director, Interim CFO	AAward	+100K sh	—	—	100,000
2015-06-12	HANSEN MEDICAL INCStock Option (Right to Buy)A Award	Director, Interim CFO	AAward	+75K sh	—	—	75,000
2014-02-25	HANSEN MEDICAL INCStock Option (Right to Buy)A Award	Director, Interim CFO	AAward	+120K sh	—	—	120,000
2013-05-30	HANSEN MEDICAL INCStock Option (Right to Buy)A Award	Director, Interim CFO	AAward	+30K sh	—	—	30,000
2013-05-17	Anthera Pharmaceuticals IncStock option (right to buy)A Award	CFO and Chief Business Officer	AAward	+1.3M sh	—	—	1,300,000
2013-05-13	HANSEN MEDICAL INCP Purchase	Director, Interim CFO	PPurchase	+12.5K sh	$1.52	+$19K	22,500
2013-03-25	Anthera Pharmaceuticals IncA Award	CFO and Chief Business Officer	AAward	+67.6K sh	—	—	108,915
2013-01-03	Anthera Pharmaceuticals IncF Tax Payment	CFO and Chief Business Officer	FTax Payment	−8,660 sh	$0.69	−$5,975.4	41,336
2012-05-25	HANSEN MEDICAL INCStock Option (Right to Buy)A Award	Director, Interim CFO	AAward	+10K sh	—	—	10,000
2012-03-30	Anthera Pharmaceuticals IncStock Option (right to buy)A Award	CFO and Chief Business Officer	AAward	+80K sh	—	—	80,000
2012-02-06	Anthera Pharmaceuticals IncA Award	CFO and Chief Business Officer	AAward	+18.8K sh	—	—	49,996

Recent filings

Accepted (ET)
Aug 264
LOWE CHRISTOPHER P.0000899243-22-029840
SEC(opens sec.gov)
May 314
LOWE CHRISTOPHER P.0000899243-22-020150
SEC(opens sec.gov)
Mar 44
LOWE CHRISTOPHER P.0001209191-22-016440
SEC(opens sec.gov)
Jan 54
LOWE CHRISTOPHER P.0001209191-22-001788
SEC(opens sec.gov)
Nov 164
LOWE CHRISTOPHER P.0001209191-21-064924
SEC(opens sec.gov)
Oct 74
LOWE CHRISTOPHER P.0001209191-21-059984
SEC(opens sec.gov)
Aug 184
LOWE CHRISTOPHER P.0001209191-21-052277
SEC(opens sec.gov)
Jun 304
LOWE CHRISTOPHER P.0001209191-21-044027
SEC(opens sec.gov)

Companies

Address

C/O ANTHERA PHARMACEUTICALS, INC. 25801 INDUSTRIAL BOULEVARD, SUITE B

HAYWARD, CA, 94545